Beranda › Kanker Urogenital
Uji klinis Kanker Urogenital yang merekrut di AS
23 studi untuk Kanker Urogenital merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Houston, TX6 studi
- Washington, DC6 studi
- Columbus, OH5 studi
- Nashville, TN5 studi
- Durham, NC4 studi
- St. Louis, MO3 studi
- New York City, NY3 studi
- Miami, FL3 studi
- Queens, NY3 studi
- Orange, CA3 studi
- Dallas, TX3 studi
- Los Angeles, CA3 studi
- Omaha, NE3 studi
- Boston, MA3 studi
- Atlanta, GA3 studi
- Ann Arbor, MI3 studi
- Cedar Rapids, IA3 studi
Berdasarkan negara bagian
- California10 studi
- Florida6 studi
- Georgia3 studi
- Illinois4 studi
- Iowa3 studi
- Maryland8 studi
- Massachusetts4 studi
- Michigan5 studi
- Minnesota3 studi
- Missouri5 studi
- Nebraska3 studi
- New York4 studi
- North Carolina6 studi
- Ohio7 studi
- South Carolina4 studi
- Tennessee5 studi
- Texas10 studi
- Virginia3 studi
- Wisconsin4 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
Surgical Thromboprophylaxis Practices in Oncology Patients Within the NCORP Network, STOP-VTE Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07215624Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Menerima pesertaFase 2
Usia 18 hingga 72 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT01174121Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradiotherapy (cCRT) in People With Muscle Invasive Bladder Cancer (EV-309)
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT07566156Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT03866382uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Sep 2026 · NCT05874921Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer
Menerima pesertaFase 2
Usia 18 hingga 72 · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT03412877Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 25 Sep 2026 · NCT06800313Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT04038619Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 10 Sep 2026 · NCT05997615A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT05592626A Multi-Center Natural History of Urothelial Cancer and Rare Genitourinary Tract Malignancies
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Agu 2026 · NCT04923178Discharge Medication Use Post-Operatively in GU Cancer Patients
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT06795087Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT03819296Repurposing Riluzole for Cancer-Related Cognitive Impairment: A Pilot Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT06580002A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
Menerima pesertaFase 1
Usia 18 ke atas · Pria · Diperbarui 9 Jul 2026 · NCT07103018Anti-tumour Activity of (177Lu) rhPSMA-10.1 Injection
Menerima pesertaFase 1/2
Usia 18 ke atas · Pria · Diperbarui 14 Mei 2026 · NCT05413850Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Apr 2026 · NCT05297734Feasibility Study of CBCT for IGRT in Cancer Patients
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT06681233Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Mar 2026 · NCT07447050Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid Tumors
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Feb 2026 · NCT04354064Gender Related Coping and Survivorship for Genitourinary Cancers
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 3 Okt 2025 · NCT05649306Prospective Data Registry and Quality of Life Assessment of Patients Undergoing Radiotherapy With the RefleXion Medical Radiotherapy System
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 15 Agu 2025 · NCT0540616718F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer
Menerima pesertaFase 4
Usia 18 ke atas · Pria · Diperbarui 27 Nov 2024 · NCT06706921Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.